Can meloxicam (nonsteroidal anti-inflammatory drug (NSAID)) cause psychological symptoms like hallucinations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Meloxicam Cause Hallucinations?

Yes, meloxicam can cause psychiatric symptoms including hallucinations, though this is a rare adverse effect. A documented case report describes a patient who developed depressive psychosis with meloxicam that resolved upon discontinuation and recurred with re-exposure 1.

Evidence for Meloxicam-Induced Psychiatric Symptoms

Direct Case Evidence

  • A 60-year-old man developed fluctuating depressive psychosis temporally associated with meloxicam administration, which resolved quickly after cessation and recurred upon re-exposure 1.
  • The psychiatric manifestations occurred alongside other signs of meloxicam intolerance including skin rash and elevated blood pressure 1.

NSAID Class Effects

  • NSAIDs as a class are not typically listed among the primary medications causing hallucinations in major guidelines addressing medication-induced psychiatric symptoms 2.
  • The American Geriatrics Society Beers Criteria identifies NSAIDs (including meloxicam) as potentially inappropriate in older adults but primarily for cardiovascular, gastrointestinal, and renal risks—not psychiatric effects 3.
  • Data from adverse event reporting systems suggest that COX-2 selective inhibitors (like meloxicam) may have a higher propensity to cause psychiatric adverse effects compared to traditional NSAIDs 1.

Risk Factors to Consider

Patient-Specific Vulnerabilities

  • History of mental illness increases risk: Approximately 40% of NSAID-related psychiatric adverse events occur in patients with pre-existing psychiatric conditions 1.
  • Advanced age increases susceptibility to medication-induced psychiatric symptoms in general 2.
  • Polypharmacy, particularly with other medications that can cause hallucinations, compounds the risk 2.

Drug Interactions

  • Meloxicam can interact with other medications to produce serious adverse effects, as demonstrated by a case of meloxicam-desmopressin interaction causing hyponatremia and seizure 4.

Clinical Management Approach

When Hallucinations Occur

  • Immediately discontinue meloxicam if psychiatric symptoms develop, as cessation typically leads to rapid resolution 1.
  • Evaluate for other potential causes of hallucinations, including medications more commonly associated with this adverse effect (opioids, anticholinergics, benzodiazepines, corticosteroids) 2.
  • Consider whether the patient has other signs of meloxicam intolerance (rash, hypertension, gastrointestinal symptoms) 1.

Prevention Strategies

  • Use meloxicam with caution in patients with a history of mental illness, as this population has higher risk of psychiatric adverse effects from COX-2 inhibitors 1.
  • Monitor elderly patients more closely, as they are particularly susceptible to medication-induced psychiatric symptoms 2.
  • Avoid combining meloxicam with other medications that can cause hallucinations or delirium 2.

Important Caveats

Rarity of This Adverse Effect

  • Psychiatric manifestations of NSAID intolerance are rare overall 1.
  • Standard meloxicam safety profiles emphasize gastrointestinal, cardiovascular, and renal adverse effects rather than psychiatric symptoms 5.
  • A tolerability study of 177 NSAID-sensitive patients found only 1.1% had adverse reactions to meloxicam, both manifesting as cutaneous symptoms rather than psychiatric effects 6.

Differential Diagnosis

  • Do not automatically attribute hallucinations to meloxicam without considering more common culprits: opioids (especially meperidine), anticholinergics (diphenhydramine, cyclobenzaprine), benzodiazepines, and corticosteroids 2.
  • Evaluate for underlying delirium from medical causes (infection, metabolic derangements) rather than medication effect alone 3.
  • Consider temporal relationship: psychiatric symptoms should appear after meloxicam initiation and resolve with discontinuation 1.

References

Guideline

Medication-Induced Hallucinations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Meloxicam.

Profiles of drug substances, excipients, and related methodology, 2020

Research

Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.